Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Malaria Journal
Published in: Malaria Journal 1/2021

Open Access 01-12-2021 | Correction

Correction to: An update on the distribution, bionomics, and insecticide susceptibility of Anopheles stephensi in Ethiopia, 2018–2020

Authors: Meshesha Balkew, Peter Mumba, Gedeon Yohannes, Ephrem Abiy, Dejene Getachew, Solomon Yared, Amha Worku, Araya Gebresilassie, Fitsum G. Tadesse, Endalamaw Gadisa, Endashaw Esayas, Temesgen Ashine, Desta Ejeta, Sisay Dugassa, Mekonnen Yohannes, Wossenseged Lemma, Delenasaw Yewhalaw, Sheleme Chibsa, Hiwot Teka, Matt Murphy, Melissa Yoshimizu, Dereje Dengela, Sarah Zohdy, Seth Irish

Published in: Malaria Journal | Issue 1/2021

Login to get access

Excerpt

Following publication of the article [1], it was brought to our attention that the following authors had been omitted from the author list: Desta Ejeta, Sisay Dugassa, Mekonnen Yohannes, Wossenseged Lemma. These authors should be included because they organized and led the collection of the field data, and they also reviewed and approved the manuscript. …
Literature
1.
Balkew M, Mumba P, Yohannes G, Abiy E, Getachew D, Yared S, Worku A, Gebresilassie A, Tadesse FG, Gadisa E, Esayas E, Ashine T, Yewhalaw D, Ejeta D, Dugassa S, Yohannes M, Lemma W, Chibsa S, Teka H, Murphy M, Yoshimizu M, Dengela D, Zohdy S, Irish S. An update on the distribution, bionomics, and insecticide susceptibility of Anopheles stephensi in Ethiopia, 2018–2020. Malar J. 2021;20:263. https://​doi.​org/​10.​1186/​s12936-021-03801-3.CrossRefPubMedPubMedCentral
Metadata
Title
Correction to: An update on the distribution, bionomics, and insecticide susceptibility of Anopheles stephensi in Ethiopia, 2018–2020
Authors
Meshesha Balkew
Peter Mumba
Gedeon Yohannes
Ephrem Abiy
Dejene Getachew
Solomon Yared
Amha Worku
Araya Gebresilassie
Fitsum G. Tadesse
Endalamaw Gadisa
Endashaw Esayas
Temesgen Ashine
Desta Ejeta
Sisay Dugassa
Mekonnen Yohannes
Wossenseged Lemma
Delenasaw Yewhalaw
Sheleme Chibsa
Hiwot Teka
Matt Murphy
Melissa Yoshimizu
Dereje Dengela
Sarah Zohdy
Seth Irish
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2021
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-021-03852-6

Other articles of this Issue 1/2021

Malaria Journal 1/2021 Go to the issue

Research

Incidence and consequences of damage to insecticide-treated mosquito nets in Kenya

Research

Ten years of monitoring malaria trend and factors associated with malaria test positivity rates in Lower Moshi

Research

From informed consent to adherence: factors influencing involvement in mass drug administration with ivermectin for malaria elimination in The Gambia

Research

Impact of seasonality and malaria control interventions on Anopheles density and species composition from three areas of Uganda with differing malaria endemicity

Research

Efficacy of interceptor® G2, a long-lasting insecticide mixture net treated with chlorfenapyr and alpha-cypermethrin against Anopheles funestus: experimental hut trials in north-eastern Tanzania

Research

A comparative analysis of the outcome of malaria case surveillance strategies in Sri Lanka in the prevention of re‐establishment phase
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits